As of 2026-05-11, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (7.69) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -283.4%.
The range of the Relative Valuation is (6.20) - (9.93) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.6x - 7.4x | 5.7x |
| Forward P/E multiples | 4.5x - 7.3x | 5.6x |
| Fair Price | (6.20) - (9.93) | (7.69) |
| Upside | -248.0% - -337.0% | -283.4% |
| Date | P/E |